Table I.
Summary statistics for HIV/AIDS, TB, and malaria drugs in the retail and procurement channels
| All countries | Matched countries* | Matched income range** | ||||
|---|---|---|---|---|---|---|
| Mean | Std dev | Mean | Std dev | Mean | Std dev | |
| Retail (IMS) sample | ||||||
| Log per capita income | 9.76 | 1.00 | 8.24 | 0.65 | 8.25 | 0.64 |
| Raw per capita income | 24,318 | 14,082 | 4610 | 2812 | 4644 | 2802 |
| Log annual treatment price | 7.01 | 1.81 | 5.45 | 1.57 | 5.43 | 1.58 |
| Raw annual treatment price | 2974 | 3858 | 574 | 827 | 570 | 822 |
| HIV prevalence per 100K | 7.93 | 23.70 | 25.41 | 42.42 | 25.02 | 42.17 |
| Gini coefficient | 34.37 | 13.12 | 40.17 | 18.37 | 40.17 | 18.22 |
| Gini coefficient missing flag | 0.07 | 0.25 | 0.13 | 0.33 | 0.12 | 0.33 |
| Tender gen. manufs. in class-ctry. | 0.75 | 2.17 | 2.52 | 3.68 | 2.48 | 3.66 |
| Retail gen. manufs. In class-ctry. | 7.98 | 17.57 | 20.32 | 29.58 | 20.01 | 29.43 |
| Originator manufs. in class-ctry. | 2.32 | 1.60 | 2.35 | 1.71 | 2.32 | 1.72 |
| Originator present in country | 0.84 | 0.37 | 0.75 | 0.43 | 0.75 | 0.43 |
| Form = *not* oral solid | 0.17 | 0.38 | 0.16 | 0.37 | 0.16 | 0.37 |
| Generic volume (mils) | 3.33 | 15.66 | 6.77 | 23.77 | 6.68 | 23.62 |
| Originator volume (mils) | 1.05 | 4.29 | 1.39 | 6.52 | 1.36 | 6.45 |
| Observations (n)† | 5790 | 1468 | 1493 | |||
| Tendered (GPRM) sample | ||||||
| Log PCI | 7.70 | 0.98 | 8.10 | 0.79 | 8.08 | 0.61 |
| Raw PCI | 3467 | 3451 | 4360 | 2990 | 3867 | 2291 |
| Log annual treatment price | 5.14 | 1.42 | 5.35 | 1.37 | 5.18 | 1.46 |
| Raw annual treatment price | 561 | 2347 | 547 | 1178 | 634 | 2704 |
| HIV prevalence per 100K | 29.23 | 49.26 | 31.47 | 42.14 | 26.21 | 55.88 |
| Gini coefficient | 37.39 | 19.14 | 43.90 | 14.15 | 38.42 | 17.74 |
| Gini coefficient missing flag | 0.17 | 0.38 | 0.05 | 0.22 | 0.13 | 0.34 |
| Tender gen. manufs. in class-ctry. | 1.93 | 1.41 | 1.92 | 1.38 | 1.90 | 1.35 |
| Retail gen. manufs. In class-ctry. | NA | NA | NA | NA | NA | NA |
| Originator manufs. in class-ctry. | 0.76 | 0.89 | 0.79 | 0.90 | 0.73 | 0.89 |
| Originator present in country | 0.45 | 0.50 | 0.46 | 0.50 | 0.44 | 0.50 |
| Form = *not* oral solid | 0.24 | 0.43 | 0.25 | 0.43 | 0.25 | 0.43 |
| Generic volume (mils) | 0.82 | 3.25 | 1.49 | 6.22 | 0.69 | 3.17 |
| Originator volume (mils) | 0.20 | 0.84 | 0.27 | 0.72 | 0.14 | 0.50 |
| Observations (n)† | 5905 | 754 | 3821 | |||
*
Matched countries = Brazil, China, Algeria, Egypt, India, Indonesia, Morocco, Philippines, Thailand, South Africa, and French West Africa. French West Africa aggregates 10 West African countries (Ivory Coast, Cameroon, Gabon, Senegal, Congo, Benin, Guinea, Togo, Mali, and Burkina Faso).
**
Matched range countries include all countries with per capita income range of the precisely matched countries by year (roughly $1K–$10K).
†
Observations at the molecule-country-year-originator/generic-formulation level.